抑制线粒体氧化磷酸化系统各复合物功能对糖酵解的影响
投稿时间:2016-10-26  修订日期:2016-10-27  点此下载全文
引用本文:米日阿依·阿里木江,殷峻.抑制线粒体氧化磷酸化系统各复合物功能对糖酵解的影响[J].医学研究杂志,2017,46(4):17-21,31
DOI: 10.11969/j.issn.1673-548X.2017.04.006
摘要点击次数: 1491
全文下载次数: 914
作者单位E-mail
米日阿依·阿里木江 200233 上海交通大学附属第六人民医院内分泌代谢科、上海市糖尿病研究所、上海市糖尿病重点实验室、上海市糖尿病临床医学中心、上海市代谢病临床医学中心  
殷峻 200233 上海交通大学附属第六人民医院内分泌代谢科、上海市糖尿病研究所、上海市糖尿病重点实验室、上海市糖尿病临床医学中心、上海市代谢病临床医学中心 yinjun@sjtu.edu.cn 
基金项目:国家自然科学基金资助项目(面上项目)(31171128);上海浦江人才计划项目(11PJ1407700)
中文摘要:目的 探讨抑制线粒体氧化磷酸化系统各复合物对细胞糖酵解的影响。方法 培养HepG2细胞,铺于96孔板,用不同浓度的线粒体氧化磷酸化系统各复合物抑制剂处理24 h后,通过检测乳酸脱氢酶(LDH)释放量确定其最大无毒剂量;用小于该最大无毒剂量的各复合物抑制剂处理细胞后,通过检测培养基的葡萄糖和乳酸浓度,判断各复合物抑制剂对细胞糖酵解的影响。结果 线粒体复合物Ⅰ、Ⅲ、Ⅴ抑制剂二甲双胍(metformin,Met)、黏噻唑(myxothiazol, Myxo)和寡霉素A(oligomycin A, Olig)可促进HepG2细胞葡萄糖消耗和乳酸生成,且其中二甲双胍的作用最强,黏噻唑其次,寡霉素A的作用最弱;线粒体复合物Ⅱ抑制剂2-噻吩甲酰三氟丙酮(2-thenoyltrifluoroacetone,TTFA)则可减少HepG2细胞葡萄糖消耗和乳酸生成;线粒体复合物Ⅳ抑制剂氰化钾(KCN)对HepG2细胞葡萄糖消耗和乳酸生成无影响。结论 抑制线粒体复合物Ⅰ、Ⅲ、Ⅴ对细胞糖代谢是有益处的;抑制线粒体复合物Ⅳ对细胞糖代谢无作用;而抑制线粒体复合物Ⅱ阻碍了细胞的糖代谢。
中文关键词:线粒体  电子传递链  葡萄糖消耗  乳酸生成  糖酵解
 
Effect of Inhibiting Each Complexes in Mitochondrial Oxidative Phosphorylation (OXPHOS) System on Glycolysis
Abstract:Objective To investigate the effect of inhibiting each complexes in mitochondrial oxidative phosphorylation (OXPHOS) system on glycolysis. Methods After human liver hepatocellular cell line HepG2 were treated with different concentrations of each inhibitor of the complexes in OXPHOS system about 24 hours, lactic dehydrogenase(LDH) release test was performed to investigate the highest nontoxic dose of each inhibitor. Then, after the cells were treated with lower concentrations than the highest nontoxic dose about 24 hours, glucose consumption and lactate production were tested to evaluate the anaerobic glycolysis effect of these inhibitors. Results The inhibition of complex Ⅰ, Ⅲ and ATP synthase(complex Ⅴ) increased the glucose consumption and lactic release in HepG2, among which the effect of complex Ⅰinhibitor metformin was the most significant, and the effect of ATP synthase inhibitor Oligomycin A was the weakest. However, The inhibitor of complex Ⅱ 2-Thenoyltrifluoroacetone (TTFA) reduced the glucose consumption and lactic release in HepG2. Last but not least, The inhibitor of complex Ⅳ KCN had no significant effect on glycolysis in HepG2. Conclusion The inhibition of Ⅰ, Ⅲ and Ⅴ can be beneficial to cell glucose metabolism. However, inhibition of complex Ⅱ can reduce cell glycolysis, which is not ideal for promoting glucose consumption, and inhibition of complex Ⅳ have no effect on cell glycolysis.
keywords:Mitochondria  Electron transport chain  Glucose consumption  Lactic release  Glycolysis
查看全文  查看/发表评论  下载PDF阅读器

京公网安备 11010502037822号